Borsi, Enrica
Mazzocchetti, Gaia
Dico, Angela Flores
Vigliotta, Ilaria
Martello, Marina
Poletti, Andrea
Solli, Vincenza
Armuzzi, Silvia
Taurisano, Barbara
Kanapari, Ajsi
Pistis, Ignazia
Zamagni, Elena
Tacchetti, Paola
Pantani, Lucia
Mancuso, Katia
Rocchi, Serena
Rizzello, Ilaria
Cavo, Michele
Terragna, Carolina
Funding for this research was provided by:
Associazione Italiana Leucemia, Linfomi e Mieloma—AIL ODV, Bologna
Ministero della Salute (RF-2016-02362532, RF-2016-02362532)
Associazione Italiana per la Ricerca sul Cancro (IG2014-15839)
Article History
Received: 9 May 2023
Accepted: 22 September 2023
First Online: 10 October 2023
Declarations
:
: The authors declare no conflicts of interest.
: All patients included in the study provided written informed consents for biological studies and have been treated following local recommendations for clinical trials or routine clinical practice at the Seràgnoli Institute, IRCCS Azienda Ospedaliero-Universitaria of Bologna, Italy.
: All authors have approved the manuscript for submission.